Gufic Biosciences Limited has been granted patent for an invention entitled "LYOPHILIZED PHARMACEUTICAL COMPOSITIONS OF DALBAVANCIN" on March 14, 2024 for the term of 20 years effective from November 23, 2016 in accordance with the provisions of the Patents Act, 1970.
Shares of Gufic Biosciences Limited was last trading in BSE at Rs. 291.80 as compared to the previous close of Rs. 283.55. The total number of shares traded during the day was 30737 in over 1042 trades.
The stock hit an intraday high of Rs. 297.35 and intraday low of 280.55. The net turnover during the day was Rs. 8759017.00.